Colon and rectal surgery is associated with high cost, long length of stay, high
postoperative surgical site infection rate, high incidence of postoperative nausea and
vomiting, and a high rate of hospital readmission. Return of bowel function is of utmost
importance in avoiding patient discomfort, morbidity, and mortality after colorectal surgery.
All patient having colorectal surgery receive neuromuscular paralysis, which is reversed at
the end of surgery with either glycopyrrolate and neostigmine, or sugammadex. Glycopyrrolate
and neostigmine both affect bowel function. Sugammadex has no effect on bowel function. The
purpose of this study is to determine if a strategy of neuromuscular reversal with
sugammadex, instead of glycopyrrolate and neostigmine, may increase gastric emptying after
surgery and lead to less postoperative complications.